Alogliptin N-Acetylated Metabolite M-II

Status: In-stock

Alogliptin N Acetylated Metabolite M II or (R)-2-((3-acetyl-6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, it is a selective, dipeptidyl peptidase-4 inhibitor that is used to treat hyperglycemia in patients with type 2 diabetes mellitus.

Additional information on Alogliptin N-Acetylated Metabolite M-II

Catalogue No. VL5900009
Molecular Formula C19H21N5O3
Molecular Weight 367.41 g/mol
Parent drug Alogliptin
IUPAC Name (R)-2-((3-acetyl-6-(3-aminopiperidin-1-yl)-2, 4-dioxo-3, 4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile
Synonyms N/A
References Dineen, Laura, et al. “Alogliptin (Nesina) for Adults with Type-2 Diabetes.” Pharmacy and Therapeutics, vol. 39, no. 3, 1 Mar. 2014, pp. 186–202,
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

Alogliptin N-Acetylated Metabolite M-II

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.